[go: up one dir, main page]

FI120198B - Menetelmä 2-(1-atsabisyklo[2.2.2]okt-3-yyli)-2,4,5,6-tetrahydro-1H-bens[de]isokinolin-1-onin ja välituotteen valmistamiseksi - Google Patents

Menetelmä 2-(1-atsabisyklo[2.2.2]okt-3-yyli)-2,4,5,6-tetrahydro-1H-bens[de]isokinolin-1-onin ja välituotteen valmistamiseksi Download PDF

Info

Publication number
FI120198B
FI120198B FI970068A FI970068A FI120198B FI 120198 B FI120198 B FI 120198B FI 970068 A FI970068 A FI 970068A FI 970068 A FI970068 A FI 970068A FI 120198 B FI120198 B FI 120198B
Authority
FI
Finland
Prior art keywords
oct
azabicyclo
benz
formula
isoquinolin
Prior art date
Application number
FI970068A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI970068A (fi
FI970068A0 (fi
Inventor
Charles Alois Dvorak
Bruce Andrew Kowalczyk
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23040964&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI120198(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI970068A publication Critical patent/FI970068A/fi
Publication of FI970068A0 publication Critical patent/FI970068A0/fi
Application granted granted Critical
Publication of FI120198B publication Critical patent/FI120198B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI970068A 1994-07-08 1997-01-07 Menetelmä 2-(1-atsabisyklo[2.2.2]okt-3-yyli)-2,4,5,6-tetrahydro-1H-bens[de]isokinolin-1-onin ja välituotteen valmistamiseksi FI120198B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US27271594 1994-07-08
US08/272,715 US5567818A (en) 1994-07-08 1994-07-08 Processes for preparing 2-(1-azabicyclo[2.2.2]oct-3-yl)-1H-benz[de] isoquinolin-1-one derivatives and intermediates useful therein
EP9502556 1995-07-01
PCT/EP1995/002556 WO1996001824A1 (en) 1994-07-08 1995-07-01 Process for the preparation of 2-(1-azabicyclo(2.2.2)oct-3-yl) -2,4,5,6-tetrahydro-1h-benz(de)isoquinolin-1-one and intermediate product

Publications (3)

Publication Number Publication Date
FI970068A FI970068A (fi) 1997-01-07
FI970068A0 FI970068A0 (fi) 1997-01-07
FI120198B true FI120198B (fi) 2009-07-31

Family

ID=23040964

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970068A FI120198B (fi) 1994-07-08 1997-01-07 Menetelmä 2-(1-atsabisyklo[2.2.2]okt-3-yyli)-2,4,5,6-tetrahydro-1H-bens[de]isokinolin-1-onin ja välituotteen valmistamiseksi

Country Status (16)

Country Link
US (1) US5567818A (es)
EP (1) EP0770077B1 (es)
JP (1) JP2898758B2 (es)
CN (1) CN1048727C (es)
AT (1) ATE205845T1 (es)
AU (1) AU2979995A (es)
BR (1) BR9508249A (es)
CL (2) CL2004001244A1 (es)
CY (1) CY2342B1 (es)
DE (1) DE69522808T2 (es)
DK (1) DK0770077T3 (es)
ES (1) ES2162929T3 (es)
FI (1) FI120198B (es)
MX (1) MX9700157A (es)
PT (1) PT770077E (es)
WO (1) WO1996001824A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001081055A1 (en) 2000-04-20 2001-11-01 Masonite Corporation Reverse molded panel
US8598219B2 (en) 2003-01-30 2013-12-03 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron
JO2735B1 (en) * 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formations of balloonosterone
US8614225B2 (en) * 2006-08-30 2013-12-24 Dr. Reddy's Laboratories Limited Process for the purification of palonosetron or its salt
EP2103612A1 (en) 2006-10-23 2009-09-23 Sicor, Inc. Crystalline forms of palonosetron hydrochloride
US20100105724A1 (en) * 2006-12-07 2010-04-29 Helsinn Healthcare Sa Crystalline and amorphous forms of palonosetron hydrochloride
EP2155199A4 (en) * 2007-05-29 2011-08-24 Chemagis Ltd NEW PALONOSETRONIC SALTS AND METHOD FOR THEIR PREPARATION AND CLEANING
WO2009010987A1 (en) * 2007-07-19 2009-01-22 Natco Pharma Limited An improved process for the preparation of pure palonosetron hydrochloride
AR069625A1 (es) * 2007-12-13 2010-02-03 Glenmark Generics Ltd Base libre de palonosetron y procedimiento para su preparacion
WO2009087643A1 (en) * 2008-01-11 2009-07-16 Natco Pharma Limited Novel crystalline forms of palonosetron hydrochloride
WO2009136405A1 (en) * 2008-05-05 2009-11-12 Natco Pharma Limited High purity palonosetron base and its solid state characteristics
WO2010056656A2 (en) * 2008-11-11 2010-05-20 Dr. Reddy's Laboratories Ltd. Preparation of crystalline palonosetron hydrochloride
CN101851233B (zh) * 2009-04-03 2013-03-06 四川滇虹医药开发有限公司 盐酸帕洛诺司琼和其前体化合物及制备
US20120267533A1 (en) 2009-06-30 2012-10-25 Ranbaxy Laboratories Limited Processes for the preparation of form i and form ii of palonosetron hydrochloride
WO2011013095A1 (en) 2009-07-31 2011-02-03 Ranbaxy Laboratories Limited Processes for the preparation of palonosetron
JP2014070036A (ja) * 2012-09-28 2014-04-21 Mitsubishi Gas Chemical Co Inc １，８−テトラリンジカルボン酸無水物の製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4007191A (en) * 1975-10-14 1977-02-08 E. R. Squibb & Sons, Inc. 2-(Piperidinyl or tetrahydropyridinyl)-alkyl)-2,3-dihydro-3-hydroxy-1H-benz(DE)isoquinolin-1-ones
CA2030718C (en) * 1989-11-28 1998-05-12 Jacob Berger Tricyclic compounds
US5202318A (en) * 1990-05-14 1993-04-13 Syntex (U.S.A.) Inc. Tricyclic compounds acting at serotonin receptor subtypes

Also Published As

Publication number Publication date
CN1152313A (zh) 1997-06-18
US5567818A (en) 1996-10-22
CL2004001244A1 (es) 2005-04-15
CN1048727C (zh) 2000-01-26
JP2898758B2 (ja) 1999-06-02
CL2007001958A1 (es) 2008-02-22
DE69522808T2 (de) 2002-04-04
WO1996001824A1 (en) 1996-01-25
BR9508249A (pt) 1998-01-06
AU2979995A (en) 1996-02-09
DE69522808D1 (de) 2001-10-25
ATE205845T1 (de) 2001-10-15
CY2342B1 (en) 2004-02-06
ES2162929T3 (es) 2002-01-16
JPH09508645A (ja) 1997-09-02
FI970068A (fi) 1997-01-07
FI970068A0 (fi) 1997-01-07
PT770077E (pt) 2002-02-28
MX9700157A (es) 1997-04-30
EP0770077A1 (en) 1997-05-02
DK0770077T3 (da) 2002-01-14
EP0770077B1 (en) 2001-09-19

Similar Documents

Publication Publication Date Title
FI120198B (fi) Menetelmä 2-(1-atsabisyklo[2.2.2]okt-3-yyli)-2,4,5,6-tetrahydro-1H-bens[de]isokinolin-1-onin ja välituotteen valmistamiseksi
EP0220601B1 (en) Pyranoindolizine derivatives and preparation process thereof
AU2003277353B2 (en) Process for the preparation of (S,S)-cis-2-benzhydryl-3-benzylaminoquinuclidine
AU2003256539B2 (en) Modified pictet-spengler reaction and products prepared therefrom
KR20070098942A (ko) 고순도의 치환된 퀴녹살린의 제조 방법
AU2002345266A1 (en) 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
US5466688A (en) Pyrido[3,4-B]indole derivatives as serotonergic agents
WO2009136405A1 (en) High purity palonosetron base and its solid state characteristics
SHIMIZU et al. Asymmetric synthesis and absolute configuration of (-)-trypargine
WO1996012721A1 (en) Indole derivatives useful as serotonergic agents
AU646485B2 (en) Indolonaphthyridines, their production and use
DE1695961A1 (de) Neue Azepin-indole und Verfahren zu deren Herstellung
FI91410B (fi) Menetelmä terapeuttisesti aktiivisten oktahydropyrrolo-pyratsino/2,1-i/indol-2-oni-johdannaisten valmistamiseksi
FR2761072A1 (fr) Derives de 2,3-dihydrofuro[3,2-b]pyridine, leur preparation et leur application en therapeutique
AU2003274627B2 (en) A method for preparing indan-1,3-dicarboxylic acid
CA2192357C (en) Process for the preparation of 2-(1-azabicyclo(2.2.2)oct-3-yl) -2,4,5,6-tetrahydro-1h-benz(de)isoquinolin-1-one and intermediate product
JP4508528B2 (ja) α−アミノ置換カルボン酸アミドの製造方法
JP5130212B2 (ja) 光学活性３−アミノ−２，５−ジオキソピロリジン−３−カルボキシレート類およびその製造方法ならびに該化合物の使用
JP2006517202A (ja) アリール縮合多環式ラクタムの製造のための方法
Nikiforov Institut fiir Organische Chemie und Biochemie der TH Darmstadt, Petersenstr. 22, D-6100 Darmstadt, BRD Stephan Stanchev, Branimir Milenkov, and Vladimir Dimitrov Institute of Organic Chemistry, Bulgarian Academy of Sciences
EP2499137A1 (en) Palonosetron metabolites
MXPA97003255A (es) Derivados de azepina tetraciclica substituida que tienen afinidad para los receptores de 5-ht2
JPH05271230A (ja) ジアザビシクロ誘導体
MXPA99006147A (es) Proceso para preparar tolterodina
IE42464B1 (en) Hexahydro-1h-indeno /1,2-b/pyridines and process for their manufacture

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 120198

Country of ref document: FI

MA Patent expired